Find an expert
Our panel of editors and experts are available for interview
Ian Mulvany
Chief Technology Officer, BMJ Group
Since joining BMJ Group in 2020 during the pandemic, Ian has led a sweeping digital transformation, strengthening the organisation’s infrastructure, accelerating its adoption of cloud-based platforms, and embedding AI and automation to improve delivery. Ian has a long track record of driving innovation in research technology. At SAGE Publishing, he founded SAGE Ocean, an incubator advancing new methods for social science research using big data. Earlier roles include Head of Technology at eLife Sciences, Head of Product at Mendeley, and Product Manager at Nature Publishing Group. He has also consistently advocated for open science, serving on the board of Dryad and the editorial board of the Journal of Open Research Software.
A recognised thought leader on digital transformation and AI in publishing, Ian has spoken at The London Book Fair, ALPSP, STM Week, and the International Association of Scientific, Technical and Medical Publishers (STM), as well as in podcasts and webinars on the future of open research, data, and AI adoption.
He regularly shares his reflections on technology, research, and innovation on his personal blog: mulvany.net
.
Theodora Bloom
Executive Editor of the BMJ
Theodora Bloom is executive editor of The BMJ. At the BMJ, Theo’s responsibilities include publishing, business, platform and operations as well as ethical and policy matters. She is a Co-Founder of the medRxiv preprint server, a collaboration between BMJ, Cold Spring Harbor Laboratory and Yale University, and jointly coordinates open access and open research initiatives at BMJ.
Professor Ronald F. van Vollenhoven
Editor-in-Chief of Lupus Science & Medicine
Professor Ronald F. van Vollenhoven is a distinguished rheumatologist and immunologist, known for his significant contributions in the field. He currently holds the position of Chair of the Department of Rheumatology and Clinical Immunology at Amsterdam UMC and directs the Amsterdam Rheumatology Centre. With a background in immunology and extensive training in Internal Medicine and Rheumatology, he has dedicated his career to the development and evaluation of biological and immunomodulatory treatments for rheumatic diseases. Dr. Van Vollenhoven has played a pivotal role in establishing crucial registries, including the Stockholm registry for biological therapies (STURE database), and has been a principal investigator in numerous clinical trials.
Professor Anna Maria Geretti
Editor-in-Chief of Sexually Transmitted Infections
Anna Maria Geretti, MD, PhD, FRCPath, is Professor of Virology & Infectious Diseases at the Institute of Infection & Global Health of the University of Liverpool, and Honorary Consultant at the Royal Liverpool University Hospital. She trained in Italy, the Netherlands and the UK and has a special interest in HIV, hepatitis B and hepatitis C infection. She has published over 100 peer-reviewed articles, editorials, reviews and book chapters, runs capacity building programmes for resource-limited countries and enthusiastically shares her expertise to train doctors and scientists.
Dr James Cave
Editor-in-Chief of the Drugs and Therapeutics Bulletin
Dr James Cave has been a GP for over 25 years. He currently works for Red Whale, providing courses for GP’s that take the latest research and demonstrate how it might be used in practice. James was awarded an OBE for services to medicine in 2009.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
